XML 32 R16.htm IDEA: XBRL DOCUMENT v3.3.1.900
Income Taxes
12 Months Ended
Dec. 31, 2015
Income Tax Disclosure [Abstract]  
Income Tax Disclosure
9. INCOME TAXES
 
The components of the income tax expense from continuing operations are as follows:
 
 
 
2015
 
2014
 
2013
 
Current
 
 
 
 
 
 
 
 
 
 
Federal
 
$
9,814,000
 
$
10,282,000
 
$
11,682,000
 
State
 
 
396,000
 
 
96,000
 
 
(202,000)
 
Total Current
 
 
10,210,000
 
 
10,378,000
 
 
11,480,000
 
 
 
 
 
 
 
 
 
 
 
 
Deferred
 
 
 
 
 
 
 
 
 
 
Federal
 
 
(125,000)
 
 
176,000
 
 
365,000
 
State
 
 
39,000
 
 
206,000
 
 
63,000
 
Foreign
 
 
(20,000)
 
 
(96,000)
 
 
-
 
Total Deferred
 
 
(106,000)
 
 
286,000
 
 
428,000
 
 
 
 
 
 
 
 
 
 
 
 
Total Income Tax Expense from Continuing Operations
 
$
10,104,000
 
$
10,664,000
 
$
11,908,000
 
 
The total tax provision for the years ended December 31, 2015, 2014, and 2013 was $9.9 million, $4.9 million, $10.0 million, respectively. Those amounts have been allocated to the following financial statement items:
 
 
 
2015
 
2014
 
2013
 
 
 
 
 
 
 
 
 
 
 
 
Income from continuing operations
 
$
10,104,000
 
$
10,664,000
 
$
11,908,000
 
Income/(loss) from discontinued operations
 
 
387,000
 
 
(5,302,000)
 
 
(1,690,000)
 
Stockholders' equity, unrealized gain (loss) on investment securities & foreign currency
 
 
(357,000)
 
 
(182,000)
 
 
143,000
 
Additional paid in capital, share-based compensation tax benefit
 
 
(247,000)
 
 
(275,000)
 
 
(383,000)
 
 
 
 
 
 
 
 
 
 
 
 
Total Income Tax Expense
 
$
9,887,000
 
$
4,905,000
 
$
9,978,000
 
 
Deferred tax assets (liabilities) consisted of the following at December 31,
 
 
 
2015
 
2014
 
2013
 
 
 
 
 
 
 
 
 
 
 
 
Reserves on inventory and sales
 
$
199,000
 
$
291,000
 
$
332,000
 
Credit and loss carryforwards
 
 
735,000
 
 
699,000
 
 
413,000
 
Stock compensation
 
 
1,149,000
 
 
1,283,000
 
 
896,000
 
Accrued expenses and deferred costs
 
 
1,068,000
 
 
3,170,000
 
 
1,260,000
 
Inventory capitalization
 
 
49,000
 
 
142,000
 
 
337,000
 
Sales tax accrual
 
 
-
 
 
8,000
 
 
337,000
 
Unrealized gain/loss on investments
 
 
85,000
 
 
-
 
 
-
 
Total deferred tax assets
 
 
3,285,000
 
 
5,593,000
 
 
3,575,000
 
 
 
 
 
 
 
 
 
 
 
 
Unrealized gain/loss on investments
 
 
-
 
 
(294,000)
 
 
(476,000)
 
Prepaid expenses
 
 
(755,000)
 
 
(779,000)
 
 
(710,000)
 
Depreciation
 
 
(6,189,000)
 
 
(6,285,000)
 
 
(7,091,000)
 
Foreign currency
 
 
(23,000)
 
 
-
 
 
-
 
Total deferred tax liabilities
 
 
(6,967,000)
 
 
(7,358,000)
 
 
(8,277,000)
 
 
 
 
 
 
 
 
 
 
 
 
Net deferred tax liabilities
 
$
(3,682,000)
 
$
(1,765,000)
 
$
(4,702,000)
 
 
The differences between the United States federal statutory tax rate and the Company's effective tax rate are as follows:
 
 
 
2015
 
2014
 
2013
 
Statutory federal tax
 
$
10,381,000
 
35.0
%
$
11,093,000
 
35.0
%
$
13,665,000
 
35.0
%
State income taxes, net of federal benefit
 
 
414,000
 
1.4
%
 
314,000
 
1.0
%
 
393,000
 
1.0
%
Foreign Taxes
 
 
15,000
 
0.1
%
 
73,000
 
0.2
%
 
-
 
0.0
%
Domestic manufacturer deduction
 
 
(824,000)
 
-2.8
%
 
(811,000)
 
-2.6
%
 
(979,000)
 
-2.5
%
Other permanent differences
 
 
4,000
 
0.0
%
 
200,000
 
0.6
%
 
173,000
 
0.4
%
Research and development and jobs credits
 
 
(247,000)
 
-0.8
%
 
(203,000)
 
-0.6
%
 
(459,000)
 
-1.2
%
Other state income tax benefits
 
 
114,000
 
0.4
%
 
(113,000)
 
-0.4
%
 
(707,000)
 
-1.8
%
Other
 
 
247,000
 
0.8
%
 
111,000
 
0.4
%
 
(178,000)
 
-0.4
%
 
 
$
10,104,000
 
34.1
%
$
10,664,000
 
33.6
%
$
11,908,000
 
30.5
%
 
The 2015, 2014 and 2013 effective tax rates were impacted by the Company’s extensive state income tax planning.  This planning includes taking advantage of Maryland’s apportionment methodology.  As a manufacturing entity based in Maryland, the Company utilizes the single sales factor apportionment method in addition to claiming new state jobs credits and research & development credits.  In 2013 the Company benefited from research and development credits effective January 1, 2013, applicable retroactively to 2012 activity. In 2014 the Company benefited from research and development credits effective January 1, 2014 in addition to filing an amended federal return to claim 2010 research and development credits due to changes in Federal regulations.
 
The Company has separate company state net operating loss carry forwards totaling $10.9 million start expiring in 2031.  Maryland state credits carry forwards totaling $201,000 will begin to expire in 2018.